|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from (used in) operating activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net loss to net cash from (used in) operating activities: | |||||
| Stock-based compensation | |||||
| Depreciation and amortization | |||||
| Inventory step-up | |||||
| Excess and obsolete inventory reserve | |||||
| Debt discount amortization | |||||
| Gain on forgiveness of PPP loan | |||||
| Gain on sale of equipment | |||||
| Non-cash lease expense | |||||
| Changes in operating assets and liabilities, net of impact of business acquisition: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued Medicaid rebates | |||||
| Accrued liabilities | |||||
| Other non-current assets and liabilities | |||||
| Net cash from (used in) operating activities | |||||
| Cash from (used in) investing activities | |||||
| Proceeds from sale of equipment | |||||
| Purchases of property and equipment | |||||
| Acquisition of business | |||||
| Purchase of product licensing rights | |||||
| Net cash from (used in) investing activities | |||||
| Cash flows from (used in) financing activities | |||||
| Net proceeds from employee stock purchase plan and stock option and stock warrant exercises | |||||
| Net proceeds from the issuance of long-term debt | |||||
| Repayment of long-term debt | |||||
| Common stock issued in private placement offering | |||||
| Proceeds from stock option exercises | |||||
| Payment of tax withholding related to net share settlement of stock option exercises | |||||
| Employee stock purchase plan | |||||
| Stock warrant exercises | |||||
| Net cash from (used in) financing activities | |||||
| Change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosures of cash flow information | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosures of non-cash investing and financing activities: | |||||
| Debt issuance costs | |||||
| Fair value of warrants issued in connection with debt agreement | |||||
| Adjustment of operating lease right-of-use assets and liabilities due to tenant allowance | |||||
| Right-of-use assets obtained in exchange for lease liabilities |
Loading...